We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
24 Feb 2021 - 28 Feb 2021
Virtual Venue
03 Mar 2021 - 05 Mar 2021
Virtual Venue

Glycated Hemoglobin Screening Reveals Undiagnosed Diabetes

By LabMedica International staff writers
Posted on 15 Oct 2020
Print article
Image: Glycated Hemoglobin (HbA1c) Screening Reveals Undiagnosed Diabetes (Photo courtesy of Diabetes.co.uk).
Image: Glycated Hemoglobin (HbA1c) Screening Reveals Undiagnosed Diabetes (Photo courtesy of Diabetes.co.uk).
Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, and unexplained weight loss.

Threshold for diagnosis of diabetes is based on the relationship between results of glucose tolerance tests, fasting glucose or glycated hemoglobin (HbA1c) and complications such as retinal problems. HbA1c has the advantages that fasting is not required and results are more stable but has the disadvantage that the test is more costly than measurement of blood glucose.

Scientists at the University of Exeter Medical School (Exeter, UK) analyzed data from 216,644 UK Biobank participants with primary care records available and an HbA1c measured at recruitment. They defined participants without a diagnosis of diabetes at recruitment as those who did not self-report diabetes or had no indications of diabetes in their primary care records before recruitment. For participants with undiagnosed diabetes, the team calculated the time that it took to receive a clinical diagnosis in their primary care records, defined as the first diagnosis code for diabetes, an HbA1c of at least 48 mmol/mol (6.5%), or a prescription for glucose-lowering medication.

The investigators reported that within the cohort, 2,022, or 1%, had undiagnosed diabetes on screening by HbA1c. Compared with those with an HbA1c of less than 48 mmol/mol, individuals with an HbA1c of at least 48 mmol/mol on screening were statistically older (mean age, 61 years versus 58 years) had obesity (mean BMI, 31 kg/m2 versus 26.6 kg/m2) and were more frequently men versus women (60% versus 45%). Of the 82% of participants with undiagnosed diabetes who had primary care records covering the period after recruitment, median time to clinical diagnosis was 2.3 years, with 23% not diagnosed at 5-year follow-up.

Katie Young, PhD, a postdoctoral research associate and lead author of the study, said, “The fact that, on average, screening identified these people two years earlier than their doctors was quite surprising to us and suggests that screening could improve patient outcomes by allowing lifestyle interventions and diabetes treatment to begin much earlier.” The study was presented at the European Association for the Study of Diabetes virtual annual meeting held 21-25, September, 2020.

Related Links:
University of Exeter Medical School


Print article

Channels

Molecular Diagnostics

view channel
Image: Blood smear from a P. falciparum culture: several red blood cells have ring stages inside them while close to the center is a schizont and on the left a trophozoite (Photo courtesy of Wikimedia Commons)

Panel of MicroRNAs Differentiates Uncomplicated and Severe Malaria in Children

MicroRNAs (miRNAs), which are rapidly released from damaged tissues into the host fluids, constitute a promising biomarker for the prognosis of severe malaria. MiRNAs comprise a class of about 20 n... Read more

Pathology

view channel
Image: The Leica Bond III stainer is fully automated Immunohistochemical and In Situ Hybridization (IHC and ISH stainer) (Photo courtesy of Leica Biosystems).

Mismatch Repair/Microsatellite Instability Evaluated Using Cytology Effusion Specimens

DNA mismatch repair (MMR) status is routinely assessed in colorectal and endometrial carcinoma as a method of cancer prevention, surveillance in patients with Lynch syndrome and their families, and for... Read more

Industry

view channel
Image: BioProfile FLEX2 Cell Culture Analyzer (Photo courtesy of Nova Biomedical)

Nova Biomedical Adds Sample Retain Collector to BioProfile FLEX2 Cell Culture Analyzer

Nova Biomedical (Waltham, MA, USA) has added a Sample Retain Collector (SRC) for its BioProfile FLEX2 automated cell culture analyzer which measures up to 16 tests including pH, gases, metabolites, osmolality,... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.